Enhancing Muscle Health Globally through
Mitochondrial Bioenergetics
CelaMza
CelaMza is a fusion of “cellular” and the Sanskrit word “Amsha” (अंश), meaning a portion or spark of life. We are pioneering science-backed, patented solutions that target the root cause of age- related muscle decline, restoring cellular vitality and transforming healthy aging.Our innovative nutraceuticals and advanced therapies directly enhance mitochondrial function and energy production for unprecedented muscle health.
There is a Global Aging Crisis
The global population aged 65 and older is projected to reach 1.7 billion by 2054, creating an unprecedented demographic shift and healthcare challenge as more people face sarcopenia: age-related muscle loss that significantly impacts mobility and quality of life.
Nature Inspired Innovation
CelaMza provides groundbreaking nutraceuticals designed to directly combat age-related muscle decline.
Hang tight!
When our attorneys say its okay to share — it'll go right here. 👇🏼
Meet our Founders
Dr. Padmakumar Narayanan
DVM, M.S., Ph.D

Chief Scientific Officer
& Co-Founder
Pranav Narayanan

Executive Director
& Co-Founder
Dr. Padmakumar Narayanan brings over 25 years of unparalleled expertise in preclinical and clinical drug development, with a deep specialization in toxicology and safety assessment, directly relevant to CelaMza's innovative solutions. His robust scientific foundation is underpinned by his Doctor in Veterinary Medicine from Kerala Agricultural University, followed by a Master of Science in Small Animal Surgery from Tamil Nadu Veterinary and Animal Sciences University and Ph.D. in Immunophysiology/Immunotoxicology from Purdue University.Having held senior leadership roles at industry giants such as Ionis Pharmaceuticals, Amgen, Janssen, GlaxoSmithKline, and currently as Head of Preclinical & Clinical Development Sciences at Wave Life Sciences, Dr. Narayanan has a distinguished track record in guiding novel therapeutics, including oligonucleotide-based medicines, through rigorous safety evaluation from early discovery through clinical trials.His profound scientific rigor and extensive experience are invaluable in ensuring the safe and successful advancement of CelaMza's proprietary OPA-1 enhancing nutraceuticals and advanced ASO therapies, making him a cornerstone in our mission to restore cellular vitality and combat sarcopenia.